Literature DB >> 21451468

Interventional cardiology. Potential benefit of adding cilostazol to antiplatelet therapy after DES implantation.

Bryony M Mearns.   

Abstract

Entities:  

Year:  2011        PMID： 21451468     DOI： 10.1038/nrcardio.2011.55

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.

Authors:  Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Cheol Whan Lee; Soo-Jin Kang; Seung-Jung Park; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Nae-Hee Lee; Yoon Haeng Cho; Won-Yong Shin; Seung-Jin Lee; Se-Whan Lee; Min-Su Hyon; Duk-Won Bang; Young-Jin Choi; Hyun-Sook Kim; Bong-Ki Lee; Keun Lee; Hoon-Ki Park; Chang-Bum Park; Sang-Gon Lee; Min-Kyu Kim; Kyoung-Ha Park; Woo-Jung Park
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.